Smith G W, Hannan S F, Scott P J, Simpson I J
Clin Exp Immunol. 1982 Apr;48(1):8-16.
Sera from four patients with systemic lupus erythematosus (SLE) were shown to contain abnormal lipoproteins which behaved as immune complexes (IC). One IC lipoprotein (IC VLDL) had the density in ultracentrifugation of very low density lipoprotein, but a markedly altered electrophoretic mobility. A second IC lipoprotein (IC LDL) had the electrophoretic mobility of very low density lipoprotein but was slightly denser than low density lipoprotein on ultracentrifugation. Both the IC VLDL and IC LDL contained IgG and behaved as IC in the Clq deviation test, platelet aggregation and rheumatoid factor inhibition assays, but not in the conglutinin and Clq binding assays and the Clq solid phase assay. These differences could be due to the low densities of the IC VLDL and IC LDL. The abnormal lipoprotein IC disappeared with clinical remission in two patients and were not present in the sera of other patients with inactive or mild SLE, Type IV hyperlipidaemia, or during prednisone therapy or plasma exchange for other conditions. These IC appeared to be markers of severe and active SLE.
研究表明,四名系统性红斑狼疮(SLE)患者的血清中含有表现为免疫复合物(IC)的异常脂蛋白。一种IC脂蛋白(IC VLDL)在超速离心时具有极低密度脂蛋白的密度,但电泳迁移率明显改变。第二种IC脂蛋白(IC LDL)具有极低密度脂蛋白的电泳迁移率,但在超速离心时比低密度脂蛋白稍密。IC VLDL和IC LDL都含有IgG,并且在Clq偏离试验、血小板聚集试验和类风湿因子抑制试验中表现为IC,但在胶固素和Clq结合试验以及Clq固相试验中则不然。这些差异可能是由于IC VLDL和IC LDL的低密度所致。两名患者的异常脂蛋白IC随着临床缓解而消失,在其他非活动或轻度SLE、IV型高脂血症患者的血清中,或在泼尼松治疗期间或因其他情况进行血浆置换时均不存在。这些IC似乎是重度和活动性SLE的标志物。